Hospital · Acute care
Clinical-grade · Operator-friendly
A single nurse sets up a session in under a minute. The chamber works through dressings, no removal, no contact, no pain.
[ Pioneering Bioelectronic Medicine ]
Chronic infected wounds
Azyro is a Luxembourg medical-device company. Our bioelectronic platform uses precisely controlled magnetic fields to disrupt bacterial biofilms, making antiseptics and antibiotics work where they couldn't before, even at concentrations below the usual effective threshold.
The problem
Diabetic Foot Ulcers: a growing global crisis
Chronic wound care is one of the most expensive, least solved problems in modern medicine, and it is accelerating.
589M*
Adults (20-79 years) living with diabetes globally
~10K €*
Average annual DFU care cost per patient
+45%*
Projected diabetes increase by 2050
* Source: IDF Global Diabetes Atlas
Why current treatments fall short
- Topical antiseptics cannot reach the deep wound pockets or biofilms where bacteria hide.
- Rising antimicrobial resistance is rendering standard antibiotic regimens progressively less effective.
- Existing procedures are painful, costly, and dressing-intensive, driving low adherence and recurring readmissions.
Our solution
A bioelectronic platform that potentiates established antimicrobials
The Azyro system is a modular, magnetic-field-driven application platform, engineered for hospitals and outpatient care.
Advanced mechanism
Precisely controlled magnetic fields disrupt bacterial cell walls and biofilms, enhancing antiseptic efficacy, enabling healing where standard therapies fail.
- Patient comfort.Painless application, no dressing removal needed between sessions.
- Modular design.Adapts to different body parts and indications without redesigning the protocol.
- Hospital + home care.Lightweight and portable, usable across the full continuum of care.
- Seamless integration.Fits existing clinical care plans, no new SOPs to learn.
- Deep-tissue reach.Targets the bacteria living in pockets where topicals never arrive.
- Synergistic, not substitutive.Magnetic field + antimicrobials, effective even below the minimum inhibitory concentration (sub-MIC).
EU Patent EP4400155 · ISO 13485 Certified · TÜV SÜD
The device
See it from every angle
Explore the Azyro Bioelectronic Application System from every angle, the same chamber and controller used in hospitals and at home.
000°
Tap to rotate
3D rendering. The actual device may differ slightly in appearance.
How it works
Disruption you can see under the microscope
A precisely calibrated, low-intensity magnetic field reaches the bacteria hiding in deep tissue and breaks down their cell walls, the very defences that shield resistant strains, so standard antimicrobials can work again.
SEM Morphological disruption of the bacterial cell wall · MRSA (S. aureus) after Azyro magnetic field
01
Reaches deep. The field passes through dressings into the tissue pockets topical antiseptics never reach.
02
Breaks defences. It disrupts bacterial cell walls and biofilm, the shields that protect resistant strains.
03
Restores efficacy. Antiseptics and antibiotics work again, even below the usual effective threshold.
In practice
From the hospital bed to the living room
Azyro was engineered for clinical-grade precision and daily-life simplicity. The same application chamber moves with the patient, from acute care to long-term recovery at home.
Home · Continuum of care
Continued in home care setting · Compliance stays high
Portable, plug-and-play. Patients continue therapy within the comfort of their home, the same protocol, the same evidence.
Preclinical evidence
Achieved
Preclinical milestone · validated
Market opportunity
A large, structurally growing global market
Growth drivers
Rising diabetes
Global prevalence is expanding the patient pool rapidly.
Aging populations
Higher correlation with diabetes and chronic wounds.
AMR crisis
Standard antibiotics losing effectiveness against resistant strains.
Limited options
No competing technology offers both deep-tissue reach and home care.
Testimonials
Trusted by the clinicians who treat chronic wounds
Early feedback from the wound-care specialists evaluating Azyro in clinical settings.
“Azyro’s research results to combat AMR bacteria are amazing. They exceed anything experts thought possible just a few years ago. Azyro has not only achieved a mindblowing scientific breakthrough. They have also managed to translate their research findings into a viable, highly effective treatment system.”
“Modern technologies with antibacterial effects play a pivotal role in preventing infections. Their correct application and development can make the difference between successful wound healing and complications. Azyro has the potential to make that difference.”
Our team
Bench-to-bedside expertise, built in Luxembourg
Azyro brings together founders, scientists, electronic engineers, and senior operators with track records in medical devices, biophysics, and regulated manufacturing.
AW
Aloyse Wagner
Chief Executive Officer
Experienced leader and serial entrepreneur.
JW
Jerry Wagner
Head of Marketing
Experienced marketing specialist.
HB
Hicham Benkhai
Scientific Director
Outstanding scientific achievements in wound healing.
JS
Jan Servaes
Technical Director
Versatile leader for technical development teams.
DL
Dr. Danai Laskaratou
Research Scientist
Biophysics specialist bridging biology & physics.
IC
Ioana Chitaigoroski
Technical Engineer
Electronic engineering & QA for medical devices.
CV
Carlos Verdonck
Sr. Electronics Eng.
Skilled project leader for electronic devices.
TF
Taylor Floyd
IT Project Manager
Hospital-IT integration specialist.
MN
Maxime Nütten
Biz Dev & Finance
Experienced finance professional.
GM
Grégory Mathis
Head of Legal
Legal expert in the medical sector.
TW
Tom Wagner
Head of Finance
Proven track record as CFO of multiple companies.
+
Join our team
We are hiring
Bioengineers, regulatory specialists, and clinical leads, get in touch.
ISO 13485 certified
1 EU patent granted
TÜV SÜD certified
TÜV SÜD certified
Partnership
Join us, and be part of our journey
Azyro is revolutionising wound care through magnetic field technology. Together, we can reduce amputations and improve patient lives globally.
Clinical partners
Collaborate on clinical trials, validation studies, and medical protocols.
Email clinical team →Investors
Fuel our growth and expansion into key European and MENA markets.
Email investor relations →Distributors
Partner with us to bring Azyro technology to hospitals worldwide.
Become a distributor →Email
Website
Headquarters
5, rue Christophe Plantin · L-2339 Luxembourg